ER+ Breast CA: Letrozole belongs to a class of drugs called aromatase inhibitors. These drugs are very effective agents for treating hormone-sensitive (estrogen receptor +) breast cancers in post-menopausal women.
Answered 12/4/2014
6.3k views
Primarily breast ca: Fda approved for breast cancers that are er+. Off-label uses of Letrozole (trade name: femara) include ovarian stimulation (but can increase risks of birth defects), gynecomastia, and in men with azoospermia.
Answered 6/27/2014
5.2k views
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question